Cita APA

Pascual-Gilabert, M., Lopez-Castel, A., & Artero, R. (2021). Myotonic dystrophy type 1 drug development: A pipeline toward the market.

Citación estilo Chicago

Pascual-Gilabert, M., A. Lopez-Castel, y R. Artero. Myotonic Dystrophy Type 1 Drug Development: A Pipeline Toward the Market. 2021.

Cita MLA

Pascual-Gilabert, M., A. Lopez-Castel, y R. Artero. Myotonic Dystrophy Type 1 Drug Development: A Pipeline Toward the Market. 2021.